Department of Chemistry and Biology, Yulin Normal College, Yulin 537000, China.
Bioinorg Chem Appl. 2011;2011:898726. doi: 10.1155/2011/898726. Epub 2011 Oct 23.
Plumbagin and its Cu (II) complex [Cu (plumbagin)(2)]·H(2)O have been synthesized, and their antioxidant activities towards the inhibitory effect on DPPH free radical, reducing power, total antioxidant capacity, and inhibition on lipid peroxidation were investigated. Plumbagin and its Cu (II) complex were found to exhibit scavenging activities on DPPH radical with the inhibitory rate of 41% and 24%, respectively. The reducing power of plumbagin was outstanding at the concentrations of 1.0, 1.5, and 2.0 mg/mL, compared to Cu (II) complex and synthetic antioxidant 2,6-di-ter-butyl-4-methylphenol (BHT); the highest level reached 1.333 for plumbagin and 0.581 for Cu (II) complex. Also, the inhibition on lipid peroxidation of plumbagin was higher than that of Cu (II) complex and BHT, 46.4% for plumbagin and 24.5% for Cu (II) complex. The results give a strong impact for designing anticancer drugs, combined with their potential cytotoxic and antioxidant activities, which can be targeted selectively against cancer cells and increase their therapeutic index and additional advantages over other anticancer drugs.
白花丹素及其铜(II)配合物[Cu(白花丹素)(2)]·H(2)O 已被合成,并研究了它们对 DPPH 自由基抑制作用、还原能力、总抗氧化能力和抑制脂质过氧化的抗氧化活性。发现白花丹素及其铜(II)配合物对 DPPH 自由基均具有清除活性,抑制率分别为 41%和 24%。在 1.0、1.5 和 2.0mg/mL 的浓度下,白花丹素的还原能力明显优于铜(II)配合物和合成抗氧化剂 2,6-二叔丁基-4-甲基苯酚(BHT);最高水平达到 1.333,铜(II)配合物为 0.581。此外,白花丹素对脂质过氧化的抑制作用也高于铜(II)配合物和 BHT,分别为 46.4%和 24.5%。这些结果为设计抗癌药物提供了有力的依据,结合其潜在的细胞毒性和抗氧化活性,可以针对癌细胞进行选择性靶向,并提高其治疗指数和其他抗癌药物的额外优势。